Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$460.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Virbac SA Announces Acquisition of Majority Stake in Centrovet
Virbac SA announced the signing of an agreement by which the Company is acquiring a majority stake in Centrovet, a Chile-based company specialized in aquaculture health products. According to this agreement, Virbac SA has purchased 51% of the shares of the Centrovet Group from its shareholders and will have the option to acquire the remaining capital stock at the end of a five year period. Financial terms of the agreement were not disclosed.
Latest Developments for Virbac SA
Latest Key Developments in Pharmaceuticals
- Baxter International Inc Receives Marketing Authorization For Hyqvia In European Union
- AMAG Pharmaceuticals Inc Announces Ferumoxytol Treatment Produced Hemoglobin Increases In Adult Iron Deficiency Anemia Patients With Gastrointestinal Disease
- Sanofi SA and Regeneron Pharmaceuticals Inc Announce Positive Phase 2a Results of Dupilumab in Asthma
- Medivir AB's Partner Announces Primary Efficacy and Safety Findings from Phase III Study of Simeprevir in Treatment
- Share this
- Link this
- Digg this
Follow Reuters